Age: 4.0
Sex: F
Vaccine: MMR, UNK, DTAPIPV, MMR
Symptoms: Periorbital swelling, Rash, Rash erythematous, Vaccination site movement impairment
Clinical narrative: red puffy eyes; rash on her upper chest and arms; Cough; developed a rash/ It was blanchable and red but it didn't itch/ It was towards her inner thigh from the injection site; developed a rash/ It was blanchable and red but it didn't itch/ It was towards her inner thigh from the injection site; the vaccine was injected on her left side/unable to walk and complained about pain in her left leg; the vaccine was injected on her left side/unable to walk; She was unable to move it (left leg); This spontaneous report has been received from a consumer (patient's mother), concerning to a 4-year-old female patient. The patient's medical history was not provided. Her concurrent conditions included autism, fruit allergy (dragonfruit), and drug hypersensitivity. Historical drug included permethrin. Concomitant medications were not provided by the reporter.  On 21-JUN-2024 (also reported as 09-JUN-2020, conflicting information) around 5:00- 5:30, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, administered subcutaneously into the left thigh (reported as left leg/ left side by the patient's mother; reported as right leg by the doctors' office) as prophylaxis (dose, scheme frequency, lot number and expiration date were not provided); and with diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX) administered for prophylaxis (formulation, dose, scheme frequency, route and anatomical location, lot number and expiration date were not  provided by the primary reporter). Doctors' office was claimed it was diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX) that she was given on the left leg. However, the patient's mother did not believe that because the vaccine she witnessed injected in the left leg was yellow and subcutaneously, which matched the description of the measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) vaccine.  On 22-JUN-2024 around 07:00, the patient was unable to walk (gait inability) and complained about pain in her left leg (vaccination site pain). She was unable to move it (vaccination site movement impairment) and the mother had to carry her. When the patient's mother called the clinic, was told her to give her paracetamol (TYLENOL), but mother gave ibuprofen because her paracetamol (TYLENOL) was expired. They had a 3-hour drive after that, and she was able to walk a little. The mom had to give another dose of pain medication around 16:00.   Subsequently, on 23-JUN-2024 (reported as Sunday), the patient developed a rash. It was blanchable and red, but it did not itch, it was towards her inner thigh from the injection site (vaccination site rash/ vaccination site erythema). That lasted until 24-JUN-2024 (reported as Monday afternoon). Therefore, on this day, the patient recovered from vaccination site rash and vaccination site erythema.  On 25-JUN-2024 (reported as Tuesday), the patient had red puffy eyes (periorbital swelling) and had a rash on her upper chest and arms (localised rash). On this day, also experienced a mild cough. Approximately on 28-JUN-2024, she recovered from cough (since the event lasted 2-3 days). Approximately on 30-JUN-2024, the patient recovered from periorbital swelling, and localised rash (these events lasted 4-5 days).   At the reporting time, the patient had not recovered from vaccination site pain; and was recovering from vaccination site movement impairment and gait inability.  The causal relationship between the events and the vaccines was not provided.